FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Calvin Scott & Phendimetrazine Yellow Tabs 35mg Recall

Phendimetrazine Yellow Tabs 35mg, packaged in a) 10-count bags (NDC 69543-0410-11) and…

Calvin Scott & Company, Inc. · Albuquerque, NM

Risk level
Class II
Reported by FDA
Aug 26, 2020
Recall ID
D-1522-2020
Check your lot numberHow we source this data

Summary

Calvin Scott & recalled Phendimetrazine Yellow Tabs 35mg starting Jul 27, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1522-2020 on Aug 26, 2020. Reason: CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches. Status: Terminated.

Why it was recalled

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Product description

Phendimetrazine Yellow Tabs 35mg, packaged in a) 10-count bags (NDC 69543-0410-11) and b) 28-count bags (NDC 69543-0410-11), and c) 56-count bags (NDC 69543-0410-11) Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Manufactured by Virtus Pharm, LLC.

Lot numbers, UPCs & expiration codes

a) Lot #: 19236, Exp. Date 10/20 b) Lot #: 19170; 19236, Exp. Date: 09/20; 19303, Exp. Date: 11/20; 19347, Exp. Date: 12/20; 19353, Exp. Date: 01/21: 20032, 20047, Exp. Date: 2/21. c) Lot #: 19236, Exp. Date 10/20

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1522-2020
Classification
Class II
Status
Terminated
Recall initiated
Jul 27, 2020
FDA report date
Aug 26, 2020
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Calvin Scott & Company, Inc.

Original FDA data

Every field from FDA enforcement report D-1522-2020, exactly as published.

Show all FDA fields
City
Albuquerque
State
NM
Status
Terminated
Country
United States
Event ID
86123
Address
209 Eubank Blvd Ne
Code information
a) Lot #: 19236, Exp. Date 10/20 b) Lot #: 19170; 19236, Exp. Date: 09/20; 19303, Exp. Date: 11/20; 19347, Exp. Date: 12/20; 19353, Exp. Date: 01/21: 20032, 20047, Exp. Date: 2/21. c) Lot #: 19236, Exp. Date 10/20
Postal code
87123-2745
Report date
Aug 26, 2020
Product type
Drugs
Recall number
D-1522-2020
Classification
Class II
Recalling firm
Calvin Scott & Company, Inc.
Termination date
Apr 11, 2024
Reason for recall
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Phendimetrazine Yellow Tabs 35mg, packaged in a) 10-count bags (NDC 69543-0410-11) and b) 28-count bags (NDC 69543-0410-11), and c) 56-count bags (NDC 69543-0410-11) Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Manufactured by Virtus Pharm, LLC.
Distribution pattern
Nationwide within the United States
Recall initiation date
Jul 27, 2020
Initial firm notification
E-Mail
Center classification date
Aug 20, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1522-2020, published Aug 26, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls